Exposure to potential drug-antimicrobial agent interactions in primary health care

被引:1
作者
Nikolic, Bozana [1 ,2 ]
Popovic, Jovan [3 ]
Becarevic, Mirjana [2 ]
Rakic, Dusica [1 ,4 ]
机构
[1] Hlth Ctr Novi Sad, Novi Sad, Serbia
[2] Univ Novi Sad, Fac Med, Dept Pharm, Hajduk Veljkova 3, Novi Sad 21000, Serbia
[3] Univ Novi Sad, Fac Med, Dept Pharmacol & Toxicol, Novi Sad, Serbia
[4] Univ Novi Sad, Fac Med, Dept Gen Educ Subjects, Novi Sad, Serbia
关键词
drug therapy; anti-bacterial agents; drug interactions; outpatients; adverse drug reaction reporting systems; pharmacovigilance; RISK; PHARMACOKINETICS; POLYPHARMACY; INHIBITION; METABOLISM; ANTACIDS;
D O I
10.2298/VSP160930383N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim. Drug-drug interactions involving antimicrobials present important and often unrecognized complications of pharmacotherapy which can be prevented. The aim of the present study was to identify the frequency and type of potential drug-antimicrobial agent interactions among outpatients and to define recommendations for their management. Methods. Cross-sectional prescription database study was conducted. The analysis randomly included 823 patients who visited Health Center Novi Sad over 1-month period (November 1-30, 2011) and had prescribed >= 2 drugs where at least one drug was antimicrobial agent for systemic use. All interacting drug combinations involving antimicrobials were identified according to Drug Interaction Facts. Additionally, based on the compendium, potential interactions were classified into categories: pharmacological mechanisms, potential clinical outcomes and management advice. Results. Overall, 88 potential clinically significant drug-antimicrobial agent interactions were identified among 69 (8.4%) exposed outpatients [ the mean age 61.7 years (SD +/- 15.4); the mean number of prescribed drugs 7.5 (SD +/- 2.9); 56.5% females]. The most common identified potential interacting pairs were benzodiazepines undergoing oxidative metabolism and clarithromycin or erythromycin, and aminophylline and ciprofloxacin. In 83.0% of all cases underlying mechanism was pharmacokinetic involving primary inhibition of metabolic pathways mediated by CYP3A4 and CYP1A2 isoenzymes. Excessive sedation (22.7%), cardiotoxicity (20.5%), miscellaneous aminophylline adverse effects (13.6%), and bleeding (10.2%) were the most frequently implicated potential clinical outcomes. Risk for adverse interactions could be managed by close monitoring of simultaneous administration of drugs (37.5%), different risk-modifyng strategies (31.8%), and avoiding combinations (30.7%). Conclusion. Among outpatients, there was common potential for clinically significant interactions involving antimicrobials. Information based on the results of the present study could be integrated in existing computerized physician order entry system in the Health Center as a form of clinical support.
引用
收藏
页码:795 / 802
页数:8
相关论文
共 50 条
  • [21] Nirmatrelvir/ritonavir drug-drug interactions in primary care outpatients
    Esquiroz, Andrea Rodriguez
    Alvarez, Lorea Sanz
    Marin, Marta Marin
    Gonzalez, Patricia Garcia
    Cobos, Paula Aldave
    Parra, Javier Garjon
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2023, 46 (03)
  • [22] Potential Drug-Drug Interactions in Prescriptions to Patients over 45 Years of Age in Primary Care, Southern Brazil
    Vieira Teixeira, Jorge Juarez
    Lonardoni Crozatti, Marcia Terezinha
    dos Santos, Carlos Aparecido
    Romano-Lieber, Nicolina Silvana
    PLOS ONE, 2012, 7 (10):
  • [23] Drug interactions detected by a computer-assisted prescription system in primary care patients in Spain: MULTIPAP study
    Rogero-Blanco, Eloisa
    Del-Cura-Gonzalez, Isabel
    Aza-Pascual-Salcedo, Mercedes
    Garcia de Blas Gonzalez, Francisca
    Terron-Rodas, Carmen
    Chimeno-Sanchez, Sergio
    Garcia-Domingo, Eva
    Lopez-Rodriguez, Juan A.
    EUROPEAN JOURNAL OF GENERAL PRACTICE, 2021, 27 (01) : 90 - 96
  • [24] Patient's lack of understanding producing insulin drug-interactions in Southeast Brazilian primary care clinics
    Peres, Heverton Alves
    Leira Pereira, Leonardo Regis
    Viana, Carlos Manuel
    Foss-Freitas, Maria Cristina
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) : 1131 - 1136
  • [25] An Organogold Compound as Potential Antimicrobial Agent against Drug-Resistant Bacteria: Initial Mechanistic Insights
    Chakraborty, Parichita
    Oosterhuis, Dorenda
    Bonsignore, Riccardo
    Casini, Angela
    Olinga, Peter
    Scheffers, Dirk-Jan
    CHEMMEDCHEM, 2021, 16 (19) : 3060 - 3070
  • [26] Potential drug-drug interactions in University Hospital Medical Intensive Care Unit patients in Turkey
    Demirkapu, M. Jafarova
    Kara, S. Pinar
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (22) : 7108 - 7114
  • [27] Evaluation of the potential drug-drug interactions at orthopedics and traumatology outpatient clinics of a tertiary care hospital
    Ozdamar, Emine Nur
    Ozdamar, Ihsan
    CUKUROVA MEDICAL JOURNAL, 2021, 46 (02): : 601 - 609
  • [28] Potential Drug-Drug Interactions in the Pediatric Intensive Care Unit of a Tertiary Care Hospital
    Rao, Chandini
    Shenoy, Varadaraj
    Udaykumar, Padmaja
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2019, 10 (02) : 63 - 68
  • [29] Drug interactions in primary health care in the George subdistrict, South Africa: a cross-sectional study
    Kapp, P. A.
    Klop, A. C.
    Jenkins, L. S.
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (01) : 78 - 84
  • [30] Prevalence of drug interactions in elderly patients with multimorbidity in primary care
    Susana Sánchez-Fidalgo
    Maria Isabel Guzmán-Ramos
    Mercedes Galván-Banqueri
    Máximo Bernabeu-Wittel
    Bernardo Santos-Ramos
    International Journal of Clinical Pharmacy, 2017, 39 : 343 - 353